HIV-1 genotypic resistance testing on low viral load specimens using the Abbott ViroSeq HIV-1 Genotyping System

Laboratory Medicine

Volumn 39, Issue 11, 2008, Pages 671-673

  Yang, Zhen ^a   Morrison, Richard ^a   Oates, Carl ^a   Sarria, Juan ^a   Patel, Janak ^a   Habibi, Afsoon ^b   Seyedjafari, Rana ^b   Hu, Peter ^b   Lennon, Alan ^b   Li, Albert ^a   Dong, Jianli ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 59849124095     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/LMVOVU1XRB9O3JZV     Document Type: Article

References (10)

1. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA. 2006;296:827-843.
2. PoAGfAA. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Department of Health and Human Services. 2008. Accessed on: April 5, 2008.
3. Mackie N, Dustan S, McClure MO, Weber JN, Clarke JR. Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia. J Virol Methods. 2004;119:73-78.
4. Mitsuya Y, Winters MA, Fessel WJ, et al. HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL. J Acquir Immune Defic Syndr. 2006;43:56-59.
5. Gale HB, Kan VL, Shinol RC. Performance of the TruGene human immunodeficiency virus type 1 genotyping kit and OpenGene DNA sequencing system on clinical samples diluted to approximately 100 copies per milliliter. Clin Vaccine Immunol. 2006;13:235-238.
6. Waters L, Mandalia S, Asboe D. Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia between 50 and 1000 copies/ml. AIDS. 2006;20:778-779.
7. Kan VL, Gale HB, Shinol RC. Response to Waters et al. "Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia..." AIDS. 2006;20:1991-1992.
8. Cornelissen M, Jurriaans S, Kozaczynska K, et al. Routine HIV-1 genotyping as a tool to identify dual infections. Aids. 2007;21:807-811.
9. Nettles RE, Kieffer TL, Simmons RP, et al. Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy. Clin Infect Dis. 2004;39:1030-1037.
10. Barber TJ. Response to Waters et al. 'Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia between 50 and 1000 copies/ml'. AIDS. 2006;20:1565.